(NASDAQ: CNXU) Conexeu Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.38%.
Conexeu Sciences's earnings in 2026 is N/A.On average, 3 Wall Street analysts forecast CNXU's earnings for 2026 to be -$10,917,399, with the lowest CNXU earnings forecast at -$10,489,265, and the highest CNXU earnings forecast at -$11,238,499. On average, 3 Wall Street analysts forecast CNXU's earnings for 2027 to be -$14,465,553, with the lowest CNXU earnings forecast at -$13,898,277, and the highest CNXU earnings forecast at -$14,891,011.
In 2028, CNXU is forecast to generate $27,839,367 in earnings, with the lowest earnings forecast at $26,747,627 and the highest earnings forecast at $28,658,171.